Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-01-18 @ 10:46 PM
Study NCT ID:
NCT01671956
Status:
TERMINATED
Last Update Posted:
2025-11-25
First Post:
2012-08-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-14
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-09
First Submit QC Date:
None
Study First Post Date:
2012-08-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-11-14
Results First Submit QC Date:
None
Results First Post Date:
2025-11-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED